The transactions resulted in a net cash inflow of Rs 183 crores for HCG in addition to the take-over of the labs and clinical research business
This is the third acquisition by Healthium this year apart from AbGel business in India and VitalCare in the UK
The acquisition expands the company’s service portfolio in the transition care segment
The company expects a potential sales turnover of Rs.350-500 crores at 100 % capacity utilization
The transaction improves patient experience, patient outcomes and aims to reduce health care costs
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
Complementary business models are the reason for the acquisition
This deal makes Meddo, one of the largest health-tech players in India
Turnover of API division of ISLL stood at Rs 856.58 crore
Growing R&D budgets of global pharmaceutical companies is the opportunity that Veeda and Bioneeds expect to capitalise on.
Subscribe To Our Newsletter & Stay Updated
